<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Initial dosing* of chromones (cromoglycates) in asthma</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Initial dosing* of chromones (cromoglycates) in asthma</h1>
<div class="graphic"><div class="figure"><div class="ttl">Initial dosing* of chromones (cromoglycates) in asthma</div><div class="cntnt"><table cellspacing="0"><colgroup span="7" width="14%"></colgroup> <tbody> <tr> <td class="subtitle1">Medication</td> <td class="subtitle1">Dose form</td> <td class="subtitle1">Availability</td> <td class="subtitle1">Trade (brand) name</td> <td class="subtitle1">Age 0 to 4</td> <td class="subtitle1">Age 5 to 11</td> <td class="subtitle1">Age 12 through adult</td> </tr> <tr> <td rowspan="4">Cromolyn sodium (sodium cromoglycate)</td> <td> <p>Nebulizer solution: 10 mg per mL in 2 mL sterile ampules</p> </td> <td> <p>United States</p> <p>Canada</p> <p>European Union (some countries)</p> <p>Other countries </p> </td> <td> <p>Various generics </p> </td> <td> <p>&gt;2 years: 2 mL (20 mg) nebulization 4 times per day</p> <p> </p> </td> <td> <p>2 mL (20 mg) nebulization 4 times per day </p> </td> <td> <p>2 mL (20 mg) nebulization 4 times daily </p> </td> </tr> <tr> <td> <p>Metered-dose inhaler; 1 mg per puff (CFC free)  </p> </td> <td> <p>European Union (some countries)</p> <p>Australia</p> <p>Other countries</p> <p><strong>Not </strong>available in US or Canada</p> </td> <td> <p>Intal CFC free</p> </td> <td>Not studied</td> <td> <p>Two puffs 4 times per day</p> </td> <td> <p>Two puffs 4 times per day</p> </td> </tr> <tr> <td> <p>Metered-dose inhaler; 5 mg per puff (CFC free) </p> </td> <td> <p>European Union (some countries)</p> <p>Australia</p> <p>Other countries</p> <p><strong>Not </strong>available in US or Canada</p> </td> <td> <p>Intal Forte CFC free</p> </td> <td>Not studied</td> <td>Two puffs 2 to 4 times per day</td> <td>Two puffs 2 to 4 times per day</td> </tr> <tr> <td> <p>Powder for inhalation capsules with spinhaler device; 20 mg per capsule </p> </td> <td> <p>European Union (some countries)</p> <p>Australia</p> <p>Other countries</p> <p><strong>Not </strong>available in US or Canada</p> </td> <td> <p>Intal Spincaps Spinhaler</p> </td> <td>Not studied</td> <td>One inhalation (20 mg) 4 times per day</td> <td>One inhalation (20 mg) 4 times per day</td> </tr> <tr class="divider_top"> <td>Nedocromil sodium</td> <td> <p>Metered-dose inhaler; 2 mg per puff (CFC free)</p> </td> <td> <p>European Union (some countries)</p> <p>Australia</p> <p>Other countries</p> <p><strong>Not </strong>available in US or Canada</p> </td> <td> <p>Tilade CFC free</p> </td> <td>&gt;2 years: Two puffs 4 times per day<sup>¶</sup></td> <td>Two puffs 4 times per day<sup><span style="font-size: 13px;">¶</span></sup></td> <td>Two puffs 4 times per day</td> </tr> </tbody></table></div><div class="graphic_footnotes">CFC: chlorofluorocarbons.<br/>* Usual doses for initiating treatment for asthma symptom prophylaxis are shown in the table. Dose may be adjusted up or downward based upon symptom control and allergen exposure. An additional dose may be given before anticipated trigger exposure. Dose recommendations vary by country; consult local licensed product information before use.<br/>¶ Not licensed for use in children age &lt;6 years in many countries where it is available.</div><div id="graphicVersion">Graphic 56418 Version 10.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
